(GSK ARIOS) follow-Up study to assess Long-Term safety and outcomes in infants and children born to mothers participating in Retosiban Treatment Studies

Project: Other project

StatusFinished
Effective start/end date9/16/169/15/18

Funding

  • GlaxoSmithKline Pharmaceuticals: $3,076.92